Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
about
Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain.Calming the "perfect storm" in methicillin-resistant Staphylococcus aureus bacteremia: a call for a more balanced discussion.Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies.Envelope Structures of Gram-Positive Bacteria.
P2860
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Use of daptomycin to treat inf ...... centrations of 1.5 to 2 μg/mL.
@en
type
label
Use of daptomycin to treat inf ...... centrations of 1.5 to 2 μg/mL.
@en
prefLabel
Use of daptomycin to treat inf ...... centrations of 1.5 to 2 μg/mL.
@en
P2093
P2860
P356
P1476
Use of daptomycin to treat inf ...... centrations of 1.5 to 2 μg/mL.
@en
P2093
John F Mohr
Linda M Spooner
Patrick M McDaneld
Paul P Belliveau
P2860
P304
P356
10.1177/1060028013508272
P407
P577
2013-11-01T00:00:00Z